Melanoma Antigen Gene Protein MAGE-11 Regulates Androgen Receptor Function by Modulating the Interdomain Interaction

REFERENCES

• Balk, S. P. 2002. Androgen receptor as a target in androgen-independent prostate cancer. Urology 60:132–138.
   PubMed Web of Science ®Google Scholar
• Callewaert, L., G. Verrijdt, V. Christiaens, A. Haelens, and F. Claessens. 2003. Dual function of an amino-terminal amphipathic helix in androgen receptor-mediated transactivation through specific and nonspecific response elements. J. Biol. Chem. 278:8212–8218.
   PubMedGoogle Scholar
• Chen, C. D., D. S. Welsbie, C. Tran, S. H. Baek, R. Chen, R. Vessella, M. G. Rosenfeld, and C. L. Sawyers. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10:33–39.
   PubMed Web of Science ®Google Scholar
• Counts, J. L., and J. I. Goodman. 1995. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83:13–15.
   PubMed Web of Science ®Google Scholar
• De Plaen, E., K. Arden, C. Traversari, J. J. Gaforio, J. P. Szikora, C. De Smet, F. Brasseur, P. van der Bruggen, B. Lethé, C. Lurquin, R. Brasseur, P. Chomez, O. De Backer, W. Cavenee, and T. Boon. 1994. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40:360–369.
   PubMed Web of Science ®Google Scholar
• De Smet, C., O. De Backer, I. Faraoni, C. Lurquin, F. Brasseur, and T. Boon. 1996. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA 93:7149–7153.
   PubMed Web of Science ®Google Scholar
• Fujimoto, N., S. Yeh, H. Y. Kang, S. Inui, H. C. Chang, A. Mizokami, and C. Chang. 1999. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. J. Biol. Chem. 274:8316–8321.
   PubMed Web of Science ®Google Scholar
• Gelmann, E. P. 2002. Molecular biology of the androgen receptor. J. Clin. Oncol. 20:3001–3015.
   PubMed Web of Science ®Google Scholar
• Gregory, C. W., X. Fei, L. A. Ponguta, B. He, H. M. Bill, F. S. French, and E. M. Wilson. 2004. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer. J. Biol. Chem. 279:7119–7130.
   PubMed Web of Science ®Google Scholar
• Gregory, C. W., B. He, R. T. Johnson, O. H. Ford, J. L. Mohler, F. S. French, and E. M. Wilson. 2001. A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res. 61:4315–4319.
   PubMed Web of Science ®Google Scholar
• Gregory, C. W., R. T. Johnson, J. L. Mohler, F. S. French, and E. M. Wilson. 2001. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res. 61:2892–2898.
   PubMed Web of Science ®Google Scholar
• Grossmann, M. E., H. Huang, and D. J. Tindall. 2001. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93:1687–1697.
   PubMed Web of Science ®Google Scholar
• He, B., S. Bai, A. T. Hnat, R. I. Kalman, J. T. Minges, C. Patterson, and E. M. Wilson. 2004. An androgen receptor NH2-terminal conserved motif interacts with carboxyl terminus of Hsp70-interacting protein CHIP. J. Biol. Chem. 279:30643–30653.
   PubMedGoogle Scholar
• He, B., N. T. Bowen, J. T. Minges, and E. M. Wilson. 2001. Androgen-induced NH2- and COOH-terminal interaction inhibits p160 coactivator recruitment by activation function 2. J. Biol. Chem. 276:42293–42301.
   PubMed Web of Science ®Google Scholar
• He, B., R. T. Gampe, A. J. Kole, A. T. Hnat, T. B. Stanley, G. An, E. L. Stewart, R. I. Kalman, J. T. Minges, and E. M. Wilson. 2004. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. Mol. Cell 16:425–438.
   PubMed Web of Science ®Google Scholar
• He, B., J. A. Kemppainen, J. J. Voegel, H. Gronemeyer, and E. M. Wilson. 1999. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain. J. Biol. Chem. 274:37219–37225.
   PubMed Web of Science ®Google Scholar
• He, B., J. A. Kemppainen, and E. M. Wilson. 2000. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J. Biol. Chem. 275:22986–22994.
   PubMed Web of Science ®Google Scholar
• He, B., L. W. Lee, J. T. Minges, and E. M. Wilson. 2002. Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J. Biol. Chem. 277:25631–25639.
   PubMed Web of Science ®Google Scholar
• He, B., J. T. Minges, L. W. Lee, and E. M. Wilson. 2002. The FXXLF motif mediates androgen receptor-specific interactions with coregulators. J. Biol. Chem. 277:10226–10235.
   PubMed Web of Science ®Google Scholar
• He, B., and E. M. Wilson. 2003. Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs. Mol. Cell. Biol. 23:2135–2150.
   PubMed Web of Science ®Google Scholar
• Huang, W., Y. Shostak, P. Tarr, C. Sawyers, and M. Carey. 1999. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem. 274:25756–25768.
   PubMed Web of Science ®Google Scholar
• Hur, E., S. J. Pfaff, E. S. Payne, H. Gron, B. M. Buehrer, and R. J. Fletterick. 2004. Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol. 2:e274.
   PubMed Web of Science ®Google Scholar
• Irvine, R. A., and G. A. Coetzee. 1999. Additional upstream coding sequences of MAGE-11. Immunogenetics 49:585.
   PubMedGoogle Scholar
• Jurk, M., E. Kremmer, U. Schwarz, R. Forster, and E. L. Winnacker. 1998. MAGE-11 protein is highly conserved in higher organisms and located predominantly in the nucleus. Int. J. Cancer 75:762–766.
   PubMedGoogle Scholar
• Kang, H. Y., S. Yeh, N. Fujimoto, and C. Chang. 1999. Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J. Biol. Chem. 274:8570–8576.
   PubMed Web of Science ®Google Scholar
• Kemppainen, J. A., M. V. Lane, M. Sar, and E. M. Wilson. 1992. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones.. J. Biol. Chem. 267:968–974.
   PubMed Web of Science ®Google Scholar
• Kemppainen, J. A., E. Langley, C. I. Wong, K. Bobseine, W. R. Kelce, and E. M. Wilson. 1999. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol. Endocrinol. 13:440–454.
   PubMed Web of Science ®Google Scholar
• Koivisto, P., J. Kononen, C. Palmberg, T. Tammela, E. Hyytinen, J. Isola, J. Trapman, K. Cleutjens, A. Noordzij, T. Visakorpi, and O. P. Kallioniemi. 1997. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res. 57:314–319.
   PubMed Web of Science ®Google Scholar
• Lalli, E., and P. Sassone-Corsi. 2003. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol. Endocrinol. 17:1445–1453.
   PubMedGoogle Scholar
• Langley, E., Z. X. Zhou, and E. M. Wilson. 1995. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J. Biol. Chem. 270:29983–29990.
   PubMed Web of Science ®Google Scholar
• Lubahn, D. B., D. R. Joseph, M. Sar, J. Tan, H. N. Higgs, R. E. Larson, F. S. French, and E. M. Wilson. 1988. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol. Endocrinol. 2:1265–1275.
   PubMed Web of Science ®Google Scholar
• Lurquin, C., C. De Smet, F. Brasseur, F. Muscatelli, V. Martelange, E. De Plaen, R. Brasseur, A. P. Monaco, and T. Boon. 1997. Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46:397–408.
   PubMed Web of Science ®Google Scholar
• Mohler, J. L., C. W. Gregory, O. H. Ford, D. Kim, C. M. Weaver, P. Petrusz, E. M. Wilson, and F. S. French. 2004. The androgen axis in recurrent prostate cancer. Clin. Cancer Res. 10:440–448.
   PubMed Web of Science ®Google Scholar
• Muscatelli, F., T. M. Strom, A. P. Walker, E. Zanaria, D. Recan, A. Meindl, B. Bardoni, S. Guioli, G. Zehetner, W. Rabl, H. P. Schwarz, J. C. Kaplan, G. Camerino, T. Meitinger, and A. P. Monaco. 1994. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372:672–676.
   PubMed Web of Science ®Google Scholar
• Muscatelli, F., A. P. Walker, E. De Plaen, A. N. Stafford, and A. P. Monaco. 1995. Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA 92:4987–4991.
   PubMed Web of Science ®Google Scholar
• Rao, M. A., H. Cheng, A. N. Quayle, H. Nishitani, C. C. Nelson, and P. S. Rennie. 2002. RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor. J. Biol. Chem. 277:48020–48027.
   PubMed Web of Science ®Google Scholar
• Razeto, A., V. Ramakrishnan, C. M. Litterst, K. Giller, C. Griesinger, T. Carlomagno, N. Lakomek, T. Heimburg, M. Lodrini, E. Pfitzner, and S. Becker. 2004. Structure of the NCoA-1/SRC-1 PAS-B domain bound to the LXXLL motif of the STAT6 transactivation domain. J. Mol. Biol. 336:319–329.
   PubMed Web of Science ®Google Scholar
• Rivera, O. J., C. S. Song, V. E. Centonze, J. D. Lechleiter, B. Chatterjee, and A. K. Roy. 2003. Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells. Mol. Endocrinol. 17:128–140.
   PubMedGoogle Scholar
• Rogner, U. C., K. Wilke, E. Steck, B. Korn, and A. Poustka. 1995. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics 29:725–731.
   PubMed Web of Science ®Google Scholar
• Sadis, S., C. Atienza, and D. Finley. 1995. Synthetic signals for ubiquitin-dependent proteolysis. Mol. Cell. Biol. 15:4086–4094.
   PubMedGoogle Scholar
• Shang, Y., M. Myers, and M. Brown. 2002. Formation of the androgen receptor transcription complex. Mol. Cell 9:601–610.
   PubMed Web of Science ®Google Scholar
• Simental, J. A., M. Sar, M. V. Lane, F. S. French, and E. M. Wilson. 1991. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J. Biol. Chem. 266:510–518.
   PubMed Web of Science ®Google Scholar
• Steketee, K., C. A. Berrevoets, H. J. Dubbink, P. Doesburg, R. Hersmus, A. O. Brinkmann, and J. Trapman. 2002. Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor. Eur. J. Biochem. 269:5780–5791.
   PubMedGoogle Scholar
• Tan, J. A., S. H. Hall, P. Petrusz, and F. S. French. 2000. Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator. Endocrinology 141:3440–3450.
   PubMedGoogle Scholar
• Tork, S., I. Hatin, J. P. Rousset, and C. Fabret. 2004. The major 5′ determinant in stop codon read-through involves two adjacent adenines. Nucleic Acids Res. 32:415–421.
   PubMed Web of Science ®Google Scholar
• Visakorpi, T., E. Hyytinen, P. Koivisto, M. Tanner, R. Keinanen, C. Palmberg, A. Palotie, T. Tammela, J. Isola, and O. P. Kallioniemi. 1995. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet. 9:401–406.
   PubMed Web of Science ®Google Scholar
• Voegel, J. J., M. J. Heine, M. Tini, V. Vivat, P. Chambon, and H. Gronemeyer. 1998. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17:507–519.
   PubMed Web of Science ®Google Scholar
• Yang, L., J. Guerrero, H. Hong, D. B. DeFranco, and M. R. Stallcup. 2000. Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 11:2007–2018.
   PubMed Web of Science ®Google Scholar
• Yeh, S., and C. Chang. 1996. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93:5517–5521.
   PubMed Web of Science ®Google Scholar
• Zhou, Z. X., B. He, S. H. Hall, E. M. Wilson, and F. S. French. 2002. Domain interactions between coregulator ARA(70) and the androgen receptor (AR). Mol. Endocrinol. 16:287–300.
   PubMed Web of Science ®Google Scholar
• Zhou, Z. X., M. V. Lane, J. A. Kemppainen, F. S. French, and E. M. Wilson. 1995. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 9:208–218.
   PubMed Web of Science ®Google Scholar
• Zhou, Z. X., M. Sar, J. A. Simental, M. V. Lane, and E. M. Wilson. 1994. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J. Biol. Chem. 269:13115–13123.
   PubMed Web of Science ®Google Scholar